Here's the live share price of Mankind Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Mankind Pharma has gained 10.12% CAGR. Over the past year, the corresponding return has been -15.06%.
Mankind Pharma’s current P/E of 50.53x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mankind Pharma | -5.22 | -5.50 | -11.46 | -4.10 | -14.64 | 17.62 | 10.23 |
| Sun Pharmaceutical Industries | -1.54 | 2.18 | 3.54 | -7.91 | -6.28 | 18.03 | 26.96 |
| Divi's Laboratories | 4.88 | 17.20 | 6.52 | 11.33 | 17.55 | 25.99 | 16.30 |
| Cipla | -5.01 | -0.80 | 0.16 | -2.69 | -6.22 | 9.91 | 13.60 |
| Torrent Pharmaceuticals | -0.87 | 1.23 | -0.57 | 8.69 | 12.00 | 28.56 | 22.33 |
| Dr. Reddy's Laboratories | -3.88 | -3.56 | -0.81 | 2.69 | -5.39 | 10.30 | 3.96 |
| Zydus Lifesciences | -5.04 | -4.32 | -0.92 | 6.63 | -3.84 | 28.26 | 16.50 |
| Lupin | 0.03 | 1.00 | 5.05 | -6.22 | -10.22 | 40.23 | 15.90 |
| Alkem Laboratories | 2.09 | 2.95 | 14.93 | 11.34 | -0.39 | 20.58 | 15.50 |
| Aurobindo Pharma | 1.83 | 3.37 | 4.92 | -8.82 | -18.84 | 26.70 | 7.45 |
| Abbott India | 1.89 | 0.74 | -9.02 | -1.68 | 3.20 | 16.12 | 13.90 |
| Laurus Labs | 1.76 | 13.33 | 14.12 | 58.25 | 100.15 | 28.22 | 28.24 |
| Biocon | 2.82 | 10.61 | 3.10 | 14.37 | 21.69 | 11.35 | -1.45 |
| Glenmark Pharmaceuticals | -1.52 | -7.92 | -11.52 | 29.12 | 5.23 | 62.51 | 28.95 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -4.76 | -8.27 | -9.97 | 0.37 | 24.83 | 13.04 |
| Anthem Biosciences | -4.55 | -9.21 | -5.74 | -5.02 | -5.02 | -1.70 | -1.02 |
| Ipca Laboratories | 1.97 | -0.60 | -7.86 | -5.43 | -17.72 | 13.22 | 2.10 |
| Ajanta Pharma | 4.28 | 5.55 | -2.67 | -0.93 | -17.49 | 27.22 | 19.01 |
| Gland Pharma | 0.21 | -1.65 | -2.90 | 34.45 | 4.10 | 1.80 | 0.94 |
| Cohance Lifesciences | -7.62 | -16.38 | -24.41 | -36.77 | -45.51 | 18.20 | 17.40 |
Over the last one year, Mankind Pharma has declined 14.64% compared to peers like Sun Pharmaceutical Industries (-6.28%), Divi's Laboratories (17.55%), Cipla (-6.22%). From a 5 year perspective, Mankind Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.96%) and Divi's Laboratories (16.30%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,418.46 | 2,412.84 |
| 10 | 2,435.21 | 2,424.75 |
| 20 | 2,445.09 | 2,444.39 |
| 50 | 2,507.15 | 2,478.27 |
| 100 | 2,491.62 | 2,486.92 |
| 200 | 2,462.94 | 2,471.72 |
In the latest quarter, Mankind Pharma saw a drop in promoter holding to 72.65%, while DII stake increased to 11.91%, FII holding fell to 12.83%, and public shareholding moved down to 2.57% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 40,72,930 | 1.88 | 992.04 | |
| 23,51,317 | 1.5 | 572.71 | |
| 13,30,911 | 0.95 | 324.17 | |
| 13,28,039 | 0.69 | 323.47 | |
| 11,03,081 | 1.4 | 268.68 | |
| 10,76,417 | 2.03 | 262.18 | |
| 10,37,596 | 2.06 | 252.73 | |
| 9,23,014 | 1.98 | 224.82 | |
| 9,14,097 | 1.35 | 222.65 | |
| 7,95,720 | 1.11 | 193.81 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Nov 05, 2025, 4:22 AM IST | Mankind Pharma - Intimation Regarding ESG Rating |
| Oct 30, 2025, 3:47 AM IST | Mankind Pharma - Intimation Regarding ESG Rating |
| Oct 29, 2025, 11:37 PM IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Credit Rating |
| Oct 29, 2025, 4:12 PM IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 27, 2025, 11:54 PM IST | Mankind Pharma - Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended On September |
Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1991PLC044843 and registration number is 044843. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 9497.80 Cr. and Equity Capital is Rs. 41.26 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mankind Pharma is ₹2,307.05 as on Nov 06, 2025.
The Mankind Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Mankind Pharma is ₹95,644.40 Cr as on Nov 06, 2025.
Today’s highest and lowest price of Mankind Pharma are ₹2,393.55 and ₹2,305.50.
The 52-week high/low is the highest and lowest price at which Mankind Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Mankind Pharma is ₹3,050.00 and 52-week low of Mankind Pharma is ₹2,115.50 as on Nov 06, 2025.
The Mankind Pharma has shown returns of -2.69% over the past day, -5.97% for the past month, -11.9% over 3 months, -15.06% over 1 year, 17.42% across 3 years, and 10.12% over 5 years.
P/E ratio of and PB ratio of Mankind Pharma are 50.53 and 6.67 on Nov 06, 2025. While the company gives a dividend yield of 0.00 per annum.